HCG gains after launching cancer center in Nagpur

HealthCare Global Enterprises rose 1.3% to Rs 255.10 at 11:14 IST on BSE after the company announced the launch of a comprehensive cancer center in Nagpur, Maharashtra.

The announcement was made after market hours yesterday, 7 June 2017.

Meanwhile, the S&P BSE Sensex was down 40.32 points or 0.13% at 31,230.96. The S&P BSE Mid-Cap index was up 33.55 points or 0.22% at 15,459.41.

On BSE, so far 2,725 shares were traded in the counter as against average daily volume of 74,989 shares in the past one quarter. The stock hit a high of Rs 256.95 and a low of Rs 253.50 so far during the day. The stock had hit a record high of Rs 289 on 17 April 2017. The stock had hit a record low of Rs 167 on 24 June 2016.

The small-cap company has equity capital of Rs 85.71 crore. Face value per share is Rs 10.

HCG NCHRI cancer center is a 125 bed dedicated comprehensive cancer hospital established in collaboration with the Nagpur Cancer Hospital and Research Institute (NCHRI), HealthCare Global Enterprises (HCG) said. The new center is based on a multi-disciplinary team, adherence to proven clinical protocols and quality norms and features advanced technology including the TrueBeam STxTM radiotherapy system, PET-CT as well as a Bone Marrow Transplant Unit, the company said.

Dr. B.S. Ajaikumar, Chairman, HCG said that the new cancer centre is dedicated to the people of central India where there is a huge and growing unmet need for high quality cancer care.

On a consolidated basis, HCG's net profit rose 115.73% to Rs 8.09 crore on 17.67% rise in net sales to Rs 182.43 crore in Q4 March 2017 over Q4 March 2016.

HCG is the largest provider of cancer care in India. Through its network of 18 comprehensive cancer centers spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.

Powered by Capital Market - Live News